Comprehensive overview of COVID-19 clinical trials

Kiran Ejaz1, Tanveer Kauser2, Amnah Siddiqa3

  • 1School of Medicine, Emory University Atlanta, GA, USA.

Insights

Global COVID-19 clinical trials show 1,528 studies, with 940 focusing on medicines and interventions. This research landscape includes pediatric and sex-specific trials, offering diverse therapeutic options for patients worldwide.

Area of Science:

  • Clinical Research
  • Global Health
  • Infectious Diseases

Background:

  • The COVID-19 pandemic necessitated a rapid global research response.
  • Understanding the scope of clinical trials is crucial for identifying treatment gaps and opportunities.

Purpose of the Study:

  • To provide a comprehensive overview of ongoing and concluded COVID-19 clinical trials globally.
  • To categorize trials by intervention type, age group, sex, and geographical location.

Main Methods:

  • A comprehensive search of 16 international trial registries was performed.
  • Data was collected on the total number of trials, participant demographics, and intervention types.

Main Results:

  • Globally, 1,528 COVID-19 trials have been reported, with 940 focusing on medicines and interventions.
  • Fifty trials included pediatric populations, while 18 and 20 trials focused exclusively on females and males, respectively.
  • Notable trial activity includes 2 in Bangladesh, 4 in Pakistan, and 13 in India.

Conclusions:

  • The global landscape of COVID-19 clinical trials is extensive, covering a wide range of interventions.
  • Physicians can leverage this information to identify potentially beneficial trials for their patients.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
185
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
320